LEWIS JOEL

CIK 00017255951 companyNORCROSS, GA

SEC Profile

Transactions

Companies

Filings

CIK

0001725595

Recent Transactions

50 trades

Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2026-01-16+84,000→ 65,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2026-01-16+91,000→ 91,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Restricted Stock Unit
2026-01-16+120,000→ 100,000 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2026-01-06$3.58/sh−37,698→ 832,592 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2026-01-05$3.91/sh−27,731→ 870,290 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2026-01-02+84,000→ 916,592 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Restricted Stock Unit
2026-01-02−84,000→ 0 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2026-01-02$4.20/sh−18,571→ 898,021 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-12-17−7,829→ 32,171 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-17$7.06/sh−7,829→ 832,592 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-17$2.86/sh+7,829→ 840,421 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-18$6.15/sh−6,783→ 832,592 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-18$2.39/sh+6,783→ 839,375 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-18−6,783→ 0 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-17−15,680→ 6,783 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-17$2.39/sh+15,680→ 848,272 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-17$6.04/sh−15,680→ 832,592 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-10$2.39/sh+1,867→ 834,459 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-10$6.03/sh−1,867→ 832,592 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-05−200→ 24,230 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-05$2.39/sh+200→ 832,792 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-05−1,867→ 22,363 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-05$6.00/sh−200→ 832,592 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-04$6.07/sh−14,420→ 832,592 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-04$2.39/sh+14,420→ 847,012 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-04−14,420→ 24,530 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-03$6.01/sh−1,300→ 832,592 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-03−1,300→ 38,950 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-03$2.39/sh+1,300→ 833,892 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-09-12$6.36/sh−14,000→ 832,592 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-09-12$2.39/sh−14,000→ 40,250 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-09-12$2.39/sh+14,000→ 846,592 total
Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-03-03$1.57/sh−56,420→ 832,592 total
Award
GALECTIN THERAPEUTICS INC$GALT
Restricted Stock Unit
2025-01-23+84,000→ 84,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2025-01-23+91,000→ 91,000 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Restricted Stock Units
2024-12-23+56,000→ 0 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2024-12-23$0.89/sh−56,000→ 897,012 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2024-12-23+56,000→ 953,012 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2024-04-24$3.39/sh+1,000→ 2,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2024-03-01$1.96/sh−152,584→ 897,716 total
Award
GALECTIN THERAPEUTICS INC$GALT
Restricted Stock Unit
2024-01-24+56,000→ 56,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2024-01-24+91,000→ 91,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2023-12-29$1.66/sh+11,606→ 1,042,300 total
Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2023-12-15$1.60/sh+12,042→ 1,030,694 total
Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2023-11-30$1.95/sh+9,880→ 1,018,652 total
Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2023-11-15$1.87/sh+10,303→ 1,008,772 total
Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2023-10-31$2.04/sh+9,444→ 998,469 total
Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2023-10-13$2.01/sh+10,035→ 989,025 total
Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2023-10-13$2.01/sh+9,585→ 989,025 total
Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2023-09-29$1.92/sh+10,035→ 979,440 total

Companies

GALECTIN THERAPEUTICS INC
Director, President and CEO
$GALT

Recent Filings

Address

C/O GALECTIN THERAPEUTICS INC. 4960 PEACHTREE INDUSTRIAL BLVD., STE 240

NORCROSS, GA, 30071

View on SEC.gov